Furthermore, genetic depletion of IL-6 prevents angiotensin II-induced hypertension (Lee et al., 2006) indicating that control of angiotensin-induced hypertension may be modulated by preventing monocyte vascular adhesion and fine tuning of IL-6 release and signaling pathway activation. The gene discussed is AGT; the disease is hypertensive disorder.